Rosaramicin versus penicillin G in experimental Pneumococcal meningitis

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Pneumococcal meningitis is a serious infection requiring effective antibiotic treatment.
• Macrolide antibiotics like rosaramicin are potential alternatives for bacterial infections.
• Penicillin G is a standard treatment for pneumococcal meningitis.

Purpose of the Study:

• To compare the efficacy of rosaramicin and penicillin G in treating experimental pneumococcal meningitis in rabbits.
• To evaluate the safety profile of rosaramicin at different dosage regimens.

Main Methods:

• Rabbits were intracisternally infected with Streptococcus pneumoniae type III.
• Treatment with rosaramicin or penicillin G was initiated 96 hours post-infection.
• Cerebrospinal fluid (CSF) drug concentrations, bacterial counts in CSF, and survival rates were monitored.
• Histopathological examination was performed on rabbits that died.

Main Results:

• Penicillin G demonstrated superior bacterial clearance from CSF compared to rosaramicin (P < 0.01).
• Penicillin G achieved higher cure rates (7/10 and 11/14 rabbits) than rosaramicin (5/15 rabbits).
• High-dose parenteral rosaramicin (250 mg/kg/day) resulted in acute enterocecitis and death in 7 of 8 rabbits.

Conclusions:

• Penicillin G is more effective than rosaramicin for treating experimental pneumococcal meningitis in rabbits.
• Rosaramicin's efficacy is limited, and high doses are associated with severe toxicity, specifically enterocecitis.
• Further investigation into rosaramicin's therapeutic potential is warranted, considering its safety concerns.